Entry Point Capital, LLC Ardelyx, Inc. Transaction History
Entry Point Capital, LLC
- $188 Million
- Q2 2025
A detailed history of Entry Point Capital, LLC transactions in Ardelyx, Inc. stock. As of the latest transaction made, Entry Point Capital, LLC holds 95,113 shares of ARDX stock, worth $532,632. This represents 0.2% of its overall portfolio holdings.
Number of Shares
95,113
Previous 31,686
200.17%
Holding current value
$532,632
Previous $155,000
140.0%
% of portfolio
0.2%
Previous 0.08%
Shares
5 transactions
Others Institutions Holding ARDX
# of Institutions
229Shares Held
164MCall Options Held
490KPut Options Held
2.35M-
Janus Henderson Group PLC London, X025MShares$140 Million0.07% of portfolio
-
Black Rock Inc. New York, NY17.6MShares$98.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA16MShares$89.8 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C311.2MShares$62.5 Million0.07% of portfolio
-
State Street Corp Boston, MA10.2MShares$57 Million0.0% of portfolio
About ARDELYX, INC.
- Ticker ARDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 154,636,000
- Market Cap $866M
- Description
- Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...